tm logo

Monitor this mark

View On USPTO

NEPHRON PHARMACEUTICALS CORPORATION
Live/Registered
REGISTERED AND RENEWED

on 07 Nov 2022

Last Applicant/ Owned by

Nephron Pharmaceuticals Corporation

4500 12th St. Ext

West Columbia

SC

29172

Serial Number

85409595 filed on 29th Aug 2011

Registration Number

4263237 registered on 25th Dec 2012

in the Principal Register

Correspondent Address

E. Eric Mills

E. Eric Mills

4141 Parklake Avenue, Suite 200

Raleigh NC 27612

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NEPHRON PHARMACEUTICALS CORPORATION

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders

First Use Date in General

30th Sep 1997

First Use Date in Commerce

30th Sep 1997

Mark Details

Serial Number

No 85409595

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 054232-00061

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

19.13.25 -

Other receptacles for laboratory use, including beakers

Legal History

Show more

Status DateAction Taken
07th Nov 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07th Nov 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07th Nov 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07th Nov 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16th May 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
16th May 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16th May 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06th May 2022TEAS SECTION 8 & 9 RECEIVED
25th Dec 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08th Aug 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED